Health Policy Project

The Health Policy Project ended in 2016. Work continued under Health Policy Plus (HP+) until 2022.


share this publication:
Share on Facebook   Share on Twitter
Estimating the Cost of HIV Treatment for Adults, Children, and Pregnant Women in Côte d’Ivoire: Final Report
Cover Image

Author(s): Health Policy Project and Ministry of Health of Côte d’Ivoire

Primary Language: English

Date: 7/15/2015


The government of Cote d'Ivoire is committed to the fight to gain control and turn the tide of the HIV epidemic. Striving to offer the best standard of HIV treatment, the country aims to adopt the new 90-90-90 target. The country also plans to roll out “test and offer” for the general population in the near future and begin piloting Option B+ for pregnant women in 2015. Such an intense scale-up of HIV treatment services will require intensified coordination to mobilize resources and effectively target those funds for treatment scale-up and sustainability.

The aim of this cost-outcome analysis study was to estimate the cost of HIV treatment scale-up and the impact of such an expansion by estimating the cost of treatment for one person per year for adults, children, and pregnant women. Currently, limited data exist around the unit cost of HIV treatment in Cote d’Ivoire. To inform policy decisions on how best to finance scale-up of treatment with the limited resources available, understanding the outcome of HIV treatment—and the levers for improving the chances of successful treatment—is critical.

The study found that the cost of the full year of treatment expected by following the national treatment guideline would be CFA142,431 (US$288) for adults, CFA217,603 (US$440) for children, CFA85,063 (US$172) for PMTCT Option B, and CFA 151,827 (US$207) for PMTCT Option B+. A total investment of approximately CFA147 billion (US$297 million) is required over the next five years, leading up to the year 2020, to achieve the 90-90-90 target and a 100 percent roll-out of the Option B+ approach for the prevention of mother-to-child transmission (PMTCT). This investment will save more than 35,000 lives and prevent more than 6,000 children from becoming infected via PMTCT compared to the status quo, in which treatment coverage increases at the historical pace.

Tags: Click to view other publications with selected tag.

Costing    Equity    Gender    Health Financing    HIV    ImpactNow    Modeling    Orphans and Vulnerable Children (OVC)    People Living With HIV (PLHIV)    Policy    Prevention of mother to child transmission of HIV (PMTCT)    Report    Scale-up    Spectrum    Universal Health Coverage (UHC)    Côte d'Ivoire  
   RSS Feed
Our Work
How We Help
Our Team
What We Do
Maternal Health
All Topics
AFR Region
AME Region
E&E Region
LAC Region
Software and Models
User Info
Privacy Policy
Site Map
Staff Intranet
The Health Policy Project is a five-year cooperative agreement funded by the U.S. Agency for International Development under Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010. The project's HIV-related activities are supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). It is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (previously Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and White Ribbon Alliance for Safe Motherhood (WRA). The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.

Copyright © 2011 Futures Group. All Rights Reserved.2021,0,14,330296